Lance Berman is Chief Medical Officer and SVP at Relypsa Inc (RLYP). They have made 1 open-market trade across 1 company since 2014, most recently 2016-09-01.
CIK 0001455189
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RLYP | SELL · 10b5-1 | 2015-12-07 | 2015-12-09 | $29.77 | $916K | -30.6% | -23.0% | -50.9% |
| RLYP | SELL | 2015-08-17 | 2015-08-19 | $24.77 | $18K | -30.6% | +0.6% | +0.6% |
| RLYP | SELL · 10b5-1 | 2015-02-24 | 2015-02-25 | $38.19 | $191K | -30.6% | +0.6% | +0.6% |
| RLYP | SELL · 10b5-1 | 2014-11-28 | 2014-12-02 | $25.00 | $125K | -30.6% | +0.6% | +0.6% |
| RLYP | SELL · 10b5-1 | 2014-11-24 | 2014-11-26 | $25.00 | $750K | -30.6% | +0.6% | +0.6% |
| RLYP | SELL · 10b5-1 | 2014-09-24 | 2014-09-25 | $22.00 | $110K | -30.6% | +0.6% | +0.6% |
| RLYP | SELL · 10b5-1 | 2014-08-22 | 2014-08-26 | $25.89 | $518K | -30.6% | +0.6% | +0.6% |
| RLYP | SELL · 10b5-1 | 2014-07-22 | 2014-07-24 | $23.92 | $1.1M | -30.6% | +0.6% | +0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.